Follow
Ilaria Guerriero
Ilaria Guerriero
Biogem
Verified email at biogem.it
Title
Cited by
Cited by
Year
The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
T Di Mambro, I Guerriero, L Aurisicchio, M Magnani, E Marra
712019
The Akt1/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells
Oncotarget, 2015
532015
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
I Guerriero, D D’Angelo, P Pallante, M Santos, M Scrima, D Malanga, ...
Oncotarget 8 (12), 19172, 2016
412016
Dysregulation of Principal Cell miRNAs Facilitates Epigenetic Regulation of AQP2 and Results in Nephrogenic Diabetes Insipidus
F Petrillo, A Iervolino, T Angrisano, S Jelen, V Costanzo, M D’Acierno, ...
J Am Soc Nephrol, 2021
182021
Serum and glucocorticoid-inducible kinase 1 (SGK1) in NSCLC therapy
I Guerriero, G Monaco, V Coppola, A Orlacchio
Pharmaceuticals 13 (11), 413, 2020
132020
The DiaCoVAb study in South Italy: immune response to Sars-CoV-2 vaccination in dialysis patients
A Fucci, S Giacobbe, I Guerriero, Y Suzumoto, EL D’Andrea, M Scrima, ...
Kidney and Blood Pressure Research 47 (7), 467-474, 2022
112022
Understanding tricky cellular and molecular interactions in pancreatic tumor microenvironment: New food for thought
A Agostini, A Orlacchio, C Carbone, I Guerriero
Frontiers in Immunology 13, 876291, 2022
82022
COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)
F Bianchi, E Dama, F Di Nicolantonio, G Baldassarre, I Guerriero, ...
ESMO Open 6 (3), 2021
72021
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer
A Agostini, I Guerriero, G Piro, G Quero, L Roberto, A Esposito, ...
Journal of Translational Medicine 21 (1), 843, 2023
62023
Implication of β2-adrenergic receptor and miR-196a correlation in neurite outgrowth of LNCaP prostate cancer cells
I Guerriero, H Ramberg, K Sagini, M Ramirez-Garrastacho, KA Taskén, ...
Plos One 16 (6), 2021
52021
Insight into Nephrocan Function in Mouse Endoderm Patterning
M Addeo, S Buonaiuto, I Guerriero, E Amendola, F Visconte, A Marino, ...
International Journal of Molecular Sciences 21 (1), 8, 2019
32019
Exploring the molecular crosstalk between pancreatic bud and mesenchyme in embryogenesis: novel signals involved
I Guerriero, MT De Angelis, F D’Angelo, R Leveque, E Savignano, ...
International journal of molecular sciences 20 (19), 4900, 2019
32019
Spatial transcriptomics identified mucin-specific O-glycosylation as a key pathway in pancreatic cancer development and a promising therapeutic target
A Agostini, I Guerriero, G Piro, F Inzani, G Quero, L Roberto, A Esposito, ...
2022
Correction: Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells
I Guerriero, D D’Angelo, P Pallante, M Santos, M Scrima, D Malanga, ...
Oncotarget 13, 755, 2022
2022
Corrigendum to ‘COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)’:[ESMO Open Volume 6, Issue 3, June 2021, 100165]
F Bianchi, E Dama, F Di Nicolantonio, G Baldassarre, I Guerriero, ...
ESMO open 6 (4), 2021
2021
Incomplete ureteral duplication with chronic hydronephrosis due to “saddle” calculosis at the junction: a rare case
G GISMONDO VELARDI, M LICO, I GUERRIERO, B S.
Il Giornale Italiano di Radiologia Medica, 2019
2019
Espressione della proteina 14-3-3 di mais GF14-6 in piante di pomodoro: possibile ruolo nella difesa da patogeni.
MR Fullone, S Visconti, PP Bettini, M Buiatti, L Camoni, I Guerriero, ...
PETRIA 11, 106-107, 2001
2001
Il Giornale Italiano di Radiologia Medica 2019 Luglio-Agosto; 6 (4): 328-33
GG VELARDI, M LICO, I GUERRIERO, S BALDARI
Incomplete ureteral duplication with chronic hydronephrosis due to “saddle” calculosis at the junction: a rare case
GG VELARDI, M LICO, I GUERRIERO, S BALDARI
The system can't perform the operation now. Try again later.
Articles 1–19